Interpretation of the ultrasound

1. Mildly enlarged fatty liver, Grade I
   • Liver is mildly enlarged (about 16.25 cm) and appears fatty.
   • No liver mass, no bile-duct dilatation, and portal vein is normal.
   • Grade I fatty liver is an early and often reversible stage, commonly associated with excess weight around the abdomen, diabetes/prediabetes, high triglycerides, or alcohol use.
2. Gallstone in the gallbladder
   • A single stone of about 15.2 mm (1.5 cm) is reported.
   • The common bile duct is normal, so there is no ultrasound evidence that the stone has entered or blocked the bile duct.
   • The report does not describe gallbladder-wall thickening or fluid around the gallbladder, so it does not suggest acute gallbladder infection at the time of scan.
3. Small uterine fibroid
   • A well-defined fibroid within the back wall of the uterus, around 23 x 16 mm (2.3 cm).
   • Ovaries and endometrium are reported normal.
   • Fibroids are benign muscle growths. This one is small. At age 60, it needs gynecology review particularly if it is new, enlarging, or associated with any bleeding after menopause.

Treatment and next steps

1. Fatty liver

• Avoid alcohol, preferably completely until liver tests are reviewed.
• If overweight, gradual loss of about 7% to 10% of body weight can substantially improve liver fat and inflammation.
• Use a Mediterranean-style or Indian home-food approach: vegetables, pulses, whole grains, nuts in measured amounts, fish/lean protein if eaten; reduce sugary drinks, sweets, fried foods, refined flour, bakery foods, and excess rice/portions.
• Aim for at least 150 minutes/week of brisk walking or similar aerobic activity, plus resistance exercises 2 days/week if medically suitable.
• Ask the physician for: LFTs (AST, ALT, bilirubin, ALP, GGT), CBC with platelets, fasting glucose/HbA1c, lipid profile, blood pressure, hepatitis B/C testing if risk factors, and thyroid testing if clinically appropriate.
• Your doctor can calculate the FIB-4 score from age, AST, ALT, and platelets to screen for liver scarring. If elevated, FibroScan/elastography or hepatology review may be needed. The AASLD fibrosis assessment guidance supports FIB-4 as an initial risk check.

2. Gallstone

• No typical symptoms: Usually no immediate surgery is required. Observation is reasonable, with dietary adjustment and awareness of warning symptoms. The NICE gallstone guideline recommends no treatment for truly asymptomatic gallbladder stones in a normal gallbladder and biliary tree.
• Repeated typical pain or complications: Consult a general surgeon for planned laparoscopic cholecystectomy, meaning keyhole removal of the gallbladder. This is the definitive treatment for symptomatic gallstones.
• Pain medicines may help an acute attack, but they do not remove the stone. “Stone-dissolving” medicines are usually not a dependable option for a 1.5 cm gallstone and recurrence is common.

3. Fibroid

• If there is no postmenopausal bleeding, pelvic pressure/pain, urinary symptoms, or increasing abdominal size, a small fibroid is often monitored with gynecology review and possibly a repeat pelvic ultrasound in about 6 to 12 months, depending on the gynecologist’s assessment.
• If there is any vaginal bleeding after menopause, do not attribute it to the fibroid. Arrange prompt gynecology evaluation, even though the endometrium was reported normal.
• Treatment is only considered if it produces symptoms or grows. Options may include observation, medication for specific symptoms, uterine artery embolization in selected cases, or surgery. At this age, management is individualized by a gynecologist.

Current guideline position

• The current NICE gallstone guideline states that people with asymptomatic gallbladder stones should be reassured that they do not need treatment unless symptoms develop. The guideline remains active, with NICE reporting no new evidence requiring a change in its recommendations.
• The EASL gallstone guideline likewise advises against prophylactic treatment in most asymptomatic patients. Surgery has risks that generally outweigh the low probability of complications in people without symptoms.
• The natural-history data in Sleisenger and Fordtran’s Gastrointestinal and Liver Disease estimate that biliary pain develops in roughly 2% per year initially; serious complications are uncommon and are usually preceded by biliary pain.

For the ultrasound report shared

Pharmacological treatment

No routine medication for an existing asymptomatic stone

Ursodeoxycholic acid, UDCA or ursodiol

• only a minority of patients achieve complete dissolution
• treatment takes months to years
• the stone type cannot be confirmed from this ultrasound alone
• stones commonly recur after stopping therapy
• it has not been shown to reliably prevent future symptoms or complications.

When UDCA can be appropriate

• Rapid weight loss, especially after bariatric surgery or a very-low-calorie diet.

Other medicines

• Antibiotics: no role unless there is gallbladder infection, such as acute cholecystitis or cholangitis.
• Pain medicines: unnecessary if no pain. If a biliary-pain episode occurs, a clinician may use an NSAID or other analgesic after considering kidney function, ulcer risk, blood thinners, and other conditions.
• Supplements, homeopathic products, “gallbladder flushes,” lemon/olive-oil remedies, and herbal stone-dissolving products do not have reliable evidence and should not replace medical assessment.

When treatment changes

• steady severe upper-right or upper-middle abdominal pain lasting more than 30 minutes
• pain with fever, chills, vomiting
• yellow eyes/skin, dark urine, pale stools
• pancreatitis-type severe upper abdominal pain radiating to the back.

Practical plan

1. Confirm that there have been no prior gallstone-type attacks in the last year.
2. Obtain liver-function tests if not already done, particularly if there is pain, jaundice, or abnormal liver symptoms.
3. Do not start UDCA independently for this 15.2 mm asymptomatic stone.
4. Continue normal balanced meals. A strict low-fat diet does not dissolve stones, but avoiding foods that clearly provoke symptoms is sensible if symptoms begin.
5. Discuss elective surgical review only if pain develops, there are special high-risk features, or diagnosis/symptom attribution is uncertain.